Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More from Stan Caplan

I think you will find that the BoD have the discretion as to how many seats, up to seven, are available each year. This year it was five.

I humbly suggest that you read the SEC proposals paying particulat notice to when and under what circumstances shareholders may propose nominees.

.

.

.

Be well

Share
New Message
Please login to post a reply